AgaMatrix launches Kroger Blood Glucose Monitoring Systems

AgaMatrix, Inc., the makers of the WaveSense(TM) line of blood glucose monitoring products, announced today the launch of the Kroger(R) Blood Glucose Monitoring System (BGM). The Kroger BGM is found exclusively at almost 2,000 Kroger and Kroger-brand stores, including Dillons, Fry's, King Soopers, Fred Meyer, Smith's and Ralphs.

Mark Woolf, Director of Pharmacy for Kroger, said, "We are excited to announce the launch of our own Kroger brand blood glucose product that features great quality and high accuracy. We plan to continue to expand our diabetes testing category to provide our diabetic patients the quality products that they want and need. After evaluating all of our options in the marketplace, we felt that the WaveSense line of blood glucose meters and strips was the best choice for Kroger."

The Kroger(R) BGM is a no code, fast test time, and low blood volume system that has WaveSense technology for high accuracy results. While most test strips are sold only in 50 and 100 ct, the Kroger(R) BGM offers a 25 ct, especially designed for people with diabetes who pay cash for their testing supplies. Test strips are less than 50% the cost of major brands.

"By providing a best-in-category blood glucose monitoring system at a value price, along with support from one of the most trusted pharmacy names, Kroger's unique approach will benefit people with diabetes," said Dave Conn, Chief Commercial Officer at AgaMatrix. "This enables even more patients to have access to WaveSense products for better control of their diabetes."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Calcium channel blockers show potential to restore cerebral blood flow in Alzheimer's disease